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Background: Reducing neointima formation and atherosclerosis are key goals in
preventing late vein graft failure. Although pharmacologic and mechanical solutions
have been proposed, the demonstration that these influence both aspects of vein graft
pathology have been lacking. Supporting grafts externally with an oversized, highly
porous polyester stent dramatically reduces neointima formation in normocholes-
terolemic pigs. However, its effects in the presence of hypercholesterolemia are
unknown.
Methods: We compared wall thickening, cholesterol concentration, foam-cell for-
mation, and the expression of the leukocyte adhesion molecule vascular cell adhe-
sion molecule 1 after 3 months in stented and unstented saphenous vein interposition
grafts into the carotid arteries of pigs fed cholesterol to cause modest hypercholes-
terolemia (11.2  1.2 mmol/L).
Results: Stenting reduced neointima formation from 5.6  0.4 to 1.2  0.2 mm2
(n 7; P .00002, paired t test) and graft cholesterol concentration from 4.7 1.2
to 2.1  1.3 mg/g wet weight (P  .02). Foam cells were observed in unstented
grafts (mean, 1.5%  0.5% of all cells) but never in stented grafts. Vascular cell
adhesion molecule 1 was strongly expressed in 53%  8% of intimal and medial
cells in unstented grafts but was weakly expressed in only 19%  3% (n  4, P 
.05) of stented grafts.
Conclusions: We conclude that external stenting with polyester favorably influences
both neointima formation and early atherosclerosis, both of which are key aspects
of vein graft disease, and that decreased expression of vascular cell adhesion
molecule 1 is part of the underlying mechanism.
Late vein graft failure between 5 and 12 years after implantationoccurs in as many as 50% of saphenous vein coronary artery bypassgrafts and requires further intervention or surgical procedures.1 Latevein graft failure occurs as a result of atherosclerosis formation on avessel wall previously thickened by smooth muscle cell hyperpla-sia.2 Reduction in vein graft thickening, neointima formation, and
atherosclerosis are key goals in preventing late vein graft failure3; both pharmaco-
logic and mechanical solutions have been proposed. Pharmacologically, intensive
lipid-lowering therapy with statins reduces the appearance of new angiographically
defined lesions in human vein grafts.4 Inhibition of vascular smooth muscle cell
proliferation with antisense oligonucleotides decreased neointima formation in vein
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grafts.5,6 Decoy oligodeoxynucleotides against the cell-cy-
cle regulator E2F also decreased cholesterol deposition in
experimental studies7 and showed a promising effect on
early clinical outcomes.8 Mechanically, it has long been
thought that increased wall tension in the vein graft when
exposed to arterial pressure is responsible for neointima
formation.9 For this reason, efforts have been made to
provide external support for the vein for a time after im-
plantation. Supporting veins with a nonporous, expanded,
polytetrafluoroethylene external stent was shown to de-
crease vein graft cholesterol uptake in cholesterol-fed rab-
bits,10 although such materials greatly increase neointima
formation and reduce final lumenal size in both rabbit and
pig vein grafts.11-13 In contrast, supporting pig vein grafts
with a highly porous, oversized, polyester external support
dramatically reduces neointima formation,14-16 and a clini-
cal trial of this concept is ongoing. However, it is not known
what influence external polyester stenting has on neointima
formation or cholesterol uptake in the presence of hyper-
cholesterolemia.
To investigate this directly, we placed saphenous vein
interposition grafts into the carotid arteries of cholesterol-
fed pigs and measured vein graft dimensions and cholesterol
content. Surrounding grafts with an oversized polyester
support significantly reduced neointima formation. Graft
cholesterol concentration and formation of foam cells was
also reduced. To investigate the mechanism underlying this
reduction, we measured the expression of the leukocyte
adhesion molecule vascular cell adhesion molecule
(VCAM) 1, which has recently been shown to be a key
mediator of atherosclerosis formation.17
Methods
Animals
Studies were performed with Large White Landrace pigs, initially
weighing 18 to 35 kg, which received humane care according to
the United Kingdom Home Office Animals Care regulations.
Diet
Twenty-two pigs received a commercially available powdered diet
(BOCM) supplemented (by weight) with 2% cholesterol, 1%
cholic acid (Sigma Chemicals, St Louis, Mo) and 10% saturated
fat (Atora suet, McDougalls Foods Ltd, Bedfordshire, United
Kingdom). This mixture was prepared daily as a wet mash (equal
measures of diet and tap water) and fed at a rate of 1 kg per pig per
day (1.5 kg per pig 35 kg in weight).
Plasma Cholesterol Analysis
Because not all pigs responded to the diet with an increase in
plasma cholesterol level, animals were bled after at least 7 days on
the diet. Blood was withdrawn from an ear vein, and plasma
cholesterol was determined enzymatically (Olympus System Re-
agent, cholesterol, Olympus Diagnostica). Only animals that
achieved a plasma cholesterol level of at least 8 mmol/L were
included in the study to maximize the stimulus for graft cholesterol
accumulation. Further plasma cholesterol determinations were
done in these pigs at the time of graft harvest.
Operative Procedures
All animals underwent bilateral saphenous vein into carotid artery
interposition grafting, as previously described.18 In brief, a 2-cm
segment of each common carotid artery was excised, beveling the
cut ends obliquely to 45°. Saphenous vein, similarly beveled, was
reversed and anastomosed end to end into the common carotid
artery by using a continuous 7-0 Prolene suture (Ethicon, Inc,
Somerville, NJ). As detailed previously, an 8-mm–diameter poly-
ester locknit velour tube externally wound with polypropylene
(Vascutek Ltd, Inchinnan, Renfrewshire, Scotland) was used to
externally stent one of the grafts in each pig. The location (left or
right) and order of performing the grafts was randomized between
procedures. The tube, which was long enough to cover both
anastomoses completely, was divided longitudinally along one
side and gently insinuated around the completed graft. The tube
was then reformed by using 3 silk ligatures.
Harvest of Grafts
Twelve weeks after implantation, the grafts were recovered. The
grafts were re-exposed, checked for blood flow (patency), and then
removed. One-centimeter segments of the proximal and distal
carotid arteries were also sampled. Grafts were divided into 2
pieces. The cut end of one half was closed with fine suture to
permit fixation with Carson’s fixative at 100 mm Hg pressure. The
other portion was divided into several pieces and frozen in liquid
nitrogen for preparation of frozen sections and chemical analysis.
A portion of carotid artery adjacent to the graft and a piece of
saphenous vein from the unoperated leg that had not been used
during the operation were also frozen.
Histologic Techniques
Wax-embedded sections (5 m) were stained with hematoxylin
and eosin or Miller’s elastic van Gieson stain, as previously
described.19 Vessel-wall dimensions were measured by means of
computer-aided planimetry.14 The area enclosed by the endothe-
lium defined the lumen, the area inside the internal elastic lamina
defined the lumen plus neointima, and the area between the inter-
nal and external elastic lamina defined the media. Lumenal en-
croachment was defined as the percentage of the area enclosed by
the internal elastic lamina occupied by the neointima. Lumenal,
intimal, and medial perimeters and areas were computed by using
the lumenal boundary and internal and external elastic laminae as
delimiters, and the average intimal, medial, and total vessel-wall
thicknesses were derived from the area and perimeter data for 5
sections from each graft, as detailed previously.14
Alternatively, 5-m frozen sections (5 m) were treated with a
saturated solution of Oil Red O in propan-2-ol and counterstained
with hematoxylin, and the percentage of cells positive for Oil Red
O was counted in 4 random 40 fields, which abutted the lumen
and included the neointima. Immunocytochemistry for myeloid
cells (macrophages) was conducted on serial sections by using the
MAC-387 monoclonal antibody (Serotec Ltd, Oxford, United
Kingdom), VCAM-1 by using the monoclonal antibody 10.2C7,20
or intercellular adhesion molecule (ICAM) 1 by using monoclonal
antibody P19C7,21 which were generous gifts of Professor Dorian
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Haskard (Cardiovascular Medicine Unit, Imperial College School
of Medicine, Hammersmith Hospital, London, United Kingdom).
Sections were fixed in ice-cold acetone and air dried. Endogenous
peroxidase activity was blocked with hydrogen peroxide, and then
the sections were treated with 20% vol/vol goat serum in phos-
phate-buffered saline. Sections were incubated overnight at 4°C
with a 1:50 dilution of Mac387 or 12 g/mL 10.2C7 antibody or
the same concentrations of isotype-specific mouse IgG diluted in
phosphate-buffered saline containing 10 mg/mL bovine serum
albumin. Sections were then washed and incubated with a 1:200
dilution of biotinylated goat anti-mouse IgG, followed by a 1:400
dilution of alakaline phosphatase–labeled ExtrAvidin. Color was
developed with 0.05% Fast Red TR/Napthol AS-MX. Nuclei were
counterstained with hematoxylin. For each vein studied, the num-
ber of VCAM-1–positive (red staining) cells was scored in 4
randomly chosen 0.25-mm2 fields, which included the most inti-
mal portion of the graft and was expressed as a percentage of the
total number of nucleated cells.
Measurement of Tissue Cholesterol Concentrations
Segments of graft comprising the whole of the vessel wall (intima,
media, and adventitia) and weighing about 90 mg were ground to
a fine powder in liquid nitrogen by using a pestle and mortar. Total
lipid was extracted with chloroform/methanol (2:1 vol/vol), dried,
and reconstituted in isopropanol for enzymatic determination of
cholesterol, as described for serum above. The nonlipid residue of
the samples was dried, and deoxyribonucleic acid concentration
was determined fluorimetrically by using the method of Kissane
and Robins.22
Figure 1. Effect of stenting on vessel-wall dimensions: A, van Gieson staining of a stented vein graft after 3 months;
B, van Gieson staining of an unstented vein graft after 3 months. The intimal medial boundary is shown with
arrows. The scale bar shows 500 m.
TABLE 1. Effect of external polyester stenting on vein graft dimensions
Parameter Unstented graft (n  7) Stented graft (n  7) P value
Intimal area (mm2) 5.6 0.4 1.2 0.2 .00002
Medial area (mm2) 8.5 1.4 1.8 0.4 .0005
Lumenal encroachment (%) 39 5 10 3 .0005
Intimal thickness (mm) 0.45 0.03 0.16 0.02 .00001
Medial thickness (mm) 0.55 0.07 0.16 0.04 .001
P values were calculated with the paired Student t test.
TABLE 2. Effect of external polyester stenting on vein graft cholesterol concentration
Parameter Unstented graft (n  7) Stented graft (n  7) P value
Cholesterol concentration (mg/g wet weight) 4.7 1.2 2.1 0.3  .02
DNA concentration (mg/g wet weight) 0.25 0.04 0.22 0.04 NS
Cholesterol concentration (mg/mg DNA) 18.8 3.0 10.9 1.5  .05
P values were calculated with the Student t test for paired data. Values are expressed as mean  SEM. NS, not significant.
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Statistical Analysis
Values are shown throughout as the mean  SEM. Significance
between groups was established by using the paired Student t test
after performing a z score for skewness with a value of less than
2.5 for normally distributed data. Nonparametric data were com-
pared with the Wilcoxon signed-rank test.
Results
Inclusion Criteria, Operative Success, and Production
of Hypercholesterolemia in Pigs
Plasma cholesterol concentration in 13 pigs fed a commer-
cial chow diet was 2.2  0.2 mmol/L. A total of 22 pigs
were fed the cholesterol-enriched diet for at least a week,
resulting in a mean plasma cholesterol level of 9.8  0.4
mmol/L. Responses ranged from 3.2 to 22.1 mmol/L, al-
though the level achieved was stable within a particular
animal (results not shown). Of the pigs, 11 achieved a
cholesterol level of at least 8 mmol/L (approximately 4
times the normal level), and these were included in the
study. Each of these pigs received an unstented graft in one
carotid artery and a graft stented with an oversized, macro-
porous, polyester stent in the other. There were 2 operative
deaths, leaving 9 pigs that completed the study. Of the 18
grafts harvested, one stented and one unstented graft in
different pigs were occluded. The results from both grafts of
these pigs were therefore excluded from analysis. Among
the 7 pigs included in the final analysis, the cholesterol-rich
diet caused an increase in plasma cholesterol levels from
2.3  0.1 mmol/L before feeding to 11.2  1.2 mmol/L (P
.001) at the time of death 13 weeks later.
Graft Neointima Formation
Unstented grafts showed thickening of the media with dis-
ruption of the elastic layers, as previously described19; an
extensive neointima with disorganized arrangement of cells
was also formed (Figure 1, B). Stenting significantly re-
duced neointimal and medial size and medial disruption
compared with that seen in unstented grafts (Figure 1, A,
and Table 1). The neointimal cross-sectional area was re-
duced by 79%, which led to a 74% decrease in encroach-
ment of the neointima into the lumen. Medial cross-sec-
tional area was also reduced by 79% in stented compared
with control grafts.
Tissue Cholesterol Concentration
Stented grafts in cholesterol-fed pigs also had significantly
reduced cholesterol concentrations (Table 2) compared with
unstented grafts, either when this was expressed per wet
weight or per milligram of DNA (ie, per cell). The concen-
tration of cholesterol in the unstented grafts was approxi-
mately 4 times greater than in samples of carotid artery
adjacent to grafts (1.16  0.39 mg/g wet weight, P  .022)
or in samples of unoperated saphenous vein from the same
animals (1.28  0.30 mg/g wet weight, P  .034). The
cholesterol levels in stented grafts was only 45% of that in
unstented grafts (P  .05) but was still approximately 70%
greater than those in the adjacent artery and vein (both P 
.02).
Presence of Foam Cells
Unstented grafts of cholesterol-fed pigs showed patchy ac-
cumulation of foam cells that could be stained with Oil Red
O (Figure 2). Foam cells stained with the myeloid cell
marker MAC 387 (not shown), indicating that they were
most likely monocyte derived. Unstented grafts showed a
significant (P  .05) accumulation of foam cells, which
accounted for 1.5%  0.5% of neointimal cells (n  6). No
foam cells were detected in any of the 7 stented grafts.
Expression of ICAM-1 and VCAM-1
To begin to understand the mechanisms underlying the
beneficial effect of the stent on foam-cell accumulation, we
measured expression of the leukocyte adhesion molecules
ICAM-1 and VCAM-1 by means of immunocytochemistry.
ICAM-1 staining was confined to the endothelium and did
not differ between stented and unstented grafts (results not
shown). In unstented grafts a high level of VCAM-1 stain-
ing was evident in 53% 8% of neointimal cells, including
the luminal surface (presumably endothelial) cells (Figure
3, A). However, in stented veins the level of VCAM-1 was
dramatically reduced (Figure 3, B). Nevertheless, weak
staining was detectable in 19%  3% of neointimal cells
(n  4, P  .05 vs unstented grafts).
Discussion
The advantages of the pig model of vein grafting used here
over the rabbit jugular vein23 or mouse vena cava24 models
is a much closer match to the human saphenous vein in
terms of lumen size and vessel-wall thickness. As a result,
the size of the graft immediately postoperatively matches
Figure 2. Foam-cell and macrophage accumulation in stented
grafts. Oil Red O staining of a section of an unstented graft with
hematoxylin counterstaining. Foam cells are indicated by arrows.
The scale bar shows 10 m. L, Lumen.
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rather than being much larger than that of the carotid ar-
tery.18 Furthermore, the medial smooth muscle cells do not
undergo extensive cell death16 and hence remain to make up
the majority of the medial and neointimal cells in addition to
ingress of adventitial cells.25 The major disadvantage of the
pig model has been the relative difficulty of studying the
effect of hypercholesterolemia, although one previous study
reported the presence of Oil Red O–positive cells in venous,
but not arterial, grafts in cholesterol-fed pigs.26 In a prelim-
inary study we used a similarly cholesterol-rich diet without
suet as an additional source of saturated fat. However, only
a doubling of mean plasma cholesterol level was obtained
(2.3  0.4 to 4.6  2.6 mmol/L), which failed to achieve
statistical significance. The magnitude of the response var-
ied widely in individual pigs, with some animals not re-
sponding at all. Inclusion of 10% by weight of saturated fat
significantly enhanced the hypercholesterolemia observed,
although individual responses were still very variable, ne-
cessitating the selection of animals before the operation.
The relatively mild hypercholesterolemia produced is con-
sistent with values in the pathophysiologic range in human
subjects, rather than the 30 to 40 mmol/L levels often
achieved in rabbit and mouse models.
The effect of external stenting to reduce neointimal and
medial thickening and ameliorate lumenal encroachment is
similar in magnitude to that previously described in normo-
cholesterolemic pigs.14 These previous studies established
that the effect of stenting was observed as early as 1 month
after graft implantation and was sustained up to 6 months.16
We chose to study the effect of stenting at 3 months in this
study because this period of cholesterol feeding has been
commonly used to produce arterial lesions in rodent exper-
iments.5,7 Also, given the very high cost of the large quan-
tities of cholesterol-enriched diet necessary to feed pigs and
their substantial weight gain, it was not feasible to prolong
the experiment further. The relatively short period of hy-
Figure 3. VCAM-1 staining in stented and unstented grafts: A, B, immunoalkaline phosphatase staining for VCAM-1
in an unstented graft; C, nonimmune staining in an unstented graft; D, immunoalkaline phosphatase staining for
VCAM-1 in a stented graft. The scale bar shows 25 m.
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percholesterolemia in our pig studies compared with expo-
sure over years in human subjects is a limitation to the
interpretation of our results. Nevertheless, we found that
even after 3 months there was an approximately 4-fold
increase in the total cholesterol concentration within the
unstented vein grafts compared with that seen in arteries and
veins from the same animal. Furthermore, this correlated
with the focal accumulation of foam cells, as previously
reported,26 albeit in relatively small numbers. The diet did
not induce the kind of gross atherosclerotic lesions pro-
duced by much higher cholesterol levels in rodents. Argu-
ably, the pattern in our pig model is more consistent with the
slow progress of atherosclerosis in human vein grafts.
Our results clearly show that external stenting with
macroporous polyester velour decreased atherosclerosis in
cholesterol-fed pigs. Although stenting with microporous
polytetrafluoroethylene was previously shown in rabbits to
reduce atherosclerotic lesion formation,10 this greatly in-
creases neointima formation and reduces final lumenal size
in both rabbit and pig vein grafts.12,27 The basis for the
efficacy of the stent on neointima formation has been dis-
cussed in detail elsewhere.16 Briefly, because an oversized
stent is effective,15 we have argued that the neoadventitia
that forms between the stent and the graft, which eventually
provides mechanical support to the graft,16 is of prime
significance. Endothelial regeneration appears to be com-
plete in both stented and unstented vein grafts. Neverthe-
less, stenting reduces the rate of smooth muscle cell prolif-
eration, and this correlates with reduced production of
platelet-derived growth factor.16 In addition, a more effec-
tive adventitial microvascular network develops when grafts
are stented with macroporous polyester than in unstented
grafts, and this does not occur when polytetrafluoroethylene
is used as an external stent.13
We show here that the reduction of atherosclerosis by
stenting is associated with a profound downregulation of the
expression of VCAM-1. Increased VCAM-1 expression is
strongly associated with atherosclerosis in rabbit and mouse
models28,29 and is found in human atheroma.30 VCAM-1 is
a marker for the earliest stages of atherosclerosis or even
predilection for atherosclerosis.29 Moreover, from recent
studies, VCAM-1 appears to be indispensable for athero-
sclerosis formation in the ApoE/ mouse.31 Therefore it
seems likely that reduced VCAM-1 is causally related to the
reduced foam-cell formation we observed after stenting,
although other mechanisms might also be involved. For
example, the pronounced adventitial network in stented
grafts might reduce atherosclerosis by promoting passive
permeation of cholesterol, although this remains to be dem-
onstrated.
The stenting procedure used here is feasible in human
subjects, and a clinical trial of this concept (the EXTENT
trial) is presently ongoing. It will, however, seek only to
determine whether stenting reduces total vessel-wall thick-
ness after 6 months, as determined by means of intravascu-
lar ultrasonography. Because detectable atherosclerosis de-
velops later, it is important to establish in experimental
studies first what the likely effect of stenting will be. Our
present study provides reassurance that the effect of stenting
on late atherosclerosis is likely to be beneficial.
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